# EDGAR Filing Document

**Accession Number:** 0001346917
**File Stem:** 0001062993-25-011140
**Filing Date:** 2025-6
**Character Count:** 111817
**Document Hash:** f8d376ade7d1023db58d12ad59948045
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-25-011140.hdr.sgml**: 20250606

**ACCESSION NUMBER**: 0001062993-25-011140

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 8

**CONFORMED PERIOD OF REPORT**: 20250627

**FILED AS OF DATE**: 20250606

**DATE AS OF CHANGE**: 20250606

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GENTOR RESOURCES INC.
- **CENTRAL INDEX KEY:** 0001346917
- **STANDARD INDUSTRIAL CLASSIFICATION:** METAL MINING [1000]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 202679777
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-130386
- **FILM NUMBER:** 251030374

**BUSINESS ADDRESS:**
- **STREET 1:** 4120 YONGE STREET, SUITE 304
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M2P 2B8
- **BUSINESS PHONE:** (416) 361-2510

**MAIL ADDRESS:**
- **STREET 1:** 4120 YONGE STREET, SUITE 304
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M2P 2B8

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GENTOR RESOURCES, INC.
- **DATE OF NAME CHANGE:** 20100518

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Gentor Resources, Inc.
- **DATE OF NAME CHANGE:** 20051214

------

**UNITED STATES** <br>**SECURITIES AND EXCHANGE COMMISSION** <br>Washington, D.C. 20549

**FORM 6-K** 

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16** <br>**UNDER THE SECURITIES EXCHANGE ACT OF 1934** 

For the month of **<u>June 2025</u>.**

Commission File Number: **<u>333-130386</u>** 

**<u>GENTOR RESOURCES INC.</u>** <br>(Exact Name of Registrant as Specified in Charter)

**4120 Yonge Street, Suite 304**<br>**Toronto, Ontario, M2P 2B8** <br>**<u>Canada</u>**<br>(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. <br>Form 20-F [X] Form 40-F [ ]

------

**SIGNATURE** 

&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
|  | **GENTOR RESOURCES INC.** |
|  | (Registrant) |
| Date: June 6, 2025 | By:&nbsp;&nbsp;&nbsp;&nbsp; */s/ Donat K. Madilo* |
|  | Name: Donat K. Madilo |
|  | Title: Chief Financial Officer |

---

------

**<u>EXHIBIT INDEX</u>**

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| [99.1](exhibit99-1.htm) | [Notice of Annual and Special Meeting of Shareholders](exhibit99-1.htm) |
| [99.2](exhibit99-2.htm) | [Management Information Circular](exhibit99-2.htm) |
| [99.3](exhibit99-3.htm) | [Form of Proxy](exhibit99-3.htm) |
| [99.4](exhibit99-4.htm) | [Voting Instruction Form](exhibit99-4.htm) |
| [99.5](exhibit99-5.htm) | [Financial Statement and MD&A Request Form](exhibit99-5.htm) |

---

------

## Exhibit 99.1

------

**GENTOR RESOURCES INC.**

4120 Yonge Street, Suite 304

Toronto, Ontario

M2P 2B8, Canada

**NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS**

**NOTICE IS HEREBY GIVEN THAT** an annual and special meeting (the "**Meeting**") of shareholders of Gentor Resources Inc. (the "**Company**") will be held at the offices of Dickinson Wright LLP at 199 Bay Street, Suite 2200, Commerce Court West, Toronto, Ontario, Canada on Friday, the 27th day of June, 2025 at the hour of 2:15 p.m. (Toronto time), for the following purposes:

&nbsp;&nbsp;&nbsp;&nbsp;(1) To receive and consider the audited consolidated financial statements of the Company as at and for the financial year ended December 31, 2024, together with the auditors' report thereon;

&nbsp;&nbsp;&nbsp;&nbsp;(2) To elect directors of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;(3) To reappoint Kreston GTA LLP, Licensed Public Accountants, as the auditors of the Company, to hold office until the close of the next annual meeting of shareholders of the Company at such remuneration as may be approved by the directors of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;(4) To consider and, if thought advisable, to reapprove by means of an ordinary resolution the Company's Stock Option Plan, as required pursuant to the rules of the NEX Board of the TSX Venture Exchange;

&nbsp;&nbsp;&nbsp;&nbsp;(5) To consider and, if thought advisable, to authorize by means of a special resolution, the consolidation of the issued and outstanding common shares of the Company by changing each two (2) common shares of the Company into one (1) common share of the Company (the "**Share Consolidation**"), and the adoption of an amendment to the memorandum of association of the Company to reflect the Share Consolidation; and

&nbsp;&nbsp;&nbsp;&nbsp;(6) To transact such other business as properly may be brought before the Meeting or any adjournment or adjournments thereof.

The specific details of the matters to be put before the Meeting as identified above are set forth in the management information circular of the Company (the "**Circular**") accompanying and forming part of this Notice. This Notice and the accompanying Circular have been sent to each director of the Company, each shareholder of the Company entitled to notice of the Meeting and the auditors of the Company.

Shareholders who are unable to attend the Meeting in person are requested to sign and return the enclosed form of proxy to the Company c/o TSX Trust Company, 301 - 100 Adelaide Street West, Toronto, Ontario, M5H 4H1, Canada.

**DATED** the 27th day of May, 2025.

**BY ORDER OF THE BOARD**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(signed) *"Geoffrey G. Farr"*

Geoffrey G. Farr

Corporate Secretary

**NOTE:** The directors have fixed the hour of 4:00 p.m. (Toronto time) on the 25th day of June, 2025 before which time the instrument of proxy to be used at the Meeting must be deposited with the Company c/o TSX Trust Company, 301 - 100 Adelaide Street West, Toronto, Ontario, M5H 4H1, Canada, provided that a proxy may be delivered to the Chairman of the Meeting on the day of the Meeting or any adjournment thereof prior to the time for voting.

------

## Exhibit 99.2

------

**GENTOR RESOURCES INC.**

**MANAGEMENT INFORMATION CIRCULAR**

**SOLICITATION OF PROXIES**

**This management information circular (the "Circular"), which is dated May 27, 2025, is furnished in connection with the solicitation of proxies by the management of GENTOR RESOURCES INC. (the "Company") for use at the annual and special meeting of shareholders of the Company (the "Meeting") to be held at the time and place and for the purposes set forth in the attached notice of annual and special meeting of shareholders (the "Notice").** It is expected that the solicitation will be by mail primarily, but proxies may also be solicited personally by the management of the Company. The cost of such solicitation will be borne by the Company.

**APPOINTMENT, REVOCATION AND DEPOSIT OF PROXIES**

Each of the persons named in the enclosed form of proxy is an officer of the Company.

**A SHAREHOLDER HAS THE RIGHT TO APPOINT A PERSON (WHO NEED NOT BE A SHAREHOLDER) TO ATTEND AND ACT FOR HIM OR HER AND ON HIS OR HER BEHALF AT THE MEETING OTHER THAN THE PERSONS DESIGNATED IN THE ENCLOSED FORM OF PROXY. SUCH RIGHT MAY BE EXERCISED BY STRIKING OUT THE NAMES OF THE PERSONS DESIGNATED IN THE FORM OF PROXY AND BY INSERTING IN THE BLANK SPACE PROVIDED FOR THAT PURPOSE THE NAME OF THE DESIRED PERSON OR BY COMPLETING ANOTHER PROPER FORM OF PROXY AND, IN EITHER CASE, DELIVERING THE COMPLETED AND EXECUTED PROXY TO THE COMPANY C/O TSX TRUST COMPANY, 301 - 100 ADELAIDE STREET WEST, TORONTO, ONTARIO, M5H 4H1, CANADA, AT ANY TIME PRIOR TO 4:00 P.M. (TORONTO TIME) ON THE 25TH DAY OF JUNE, 2025, OR TO THE CHAIRMAN OF THE MEETING ON THE DAY OF THE MEETING OR ANY ADJOURNMENT THEREOF PRIOR TO THE TIME FOR VOTING**.

A shareholder forwarding the enclosed form of proxy may indicate the manner in which the appointee is to vote with respect to any specific item by checking the appropriate space. If the shareholder giving the proxy wishes to confer a discretionary authority with respect to any item of business, then the space opposite the item is to be left blank. The shares represented by the proxy submitted by a shareholder will be voted in accordance with the directions, if any, given in the proxy.

A shareholder who has given a proxy may revoke it at any time in so far as it has not been exercised. A proxy may be revoked, as to any matter on which a vote shall not already have been cast pursuant to the authority conferred by such proxy, by instrument in writing executed by the shareholder or by his or her attorney authorized in writing or, if the shareholder is a body corporate, by an officer or attorney thereof duly authorized, and deposited at the registered office of the Company at any time prior to 4:00 p.m. (Toronto time) on the last business day preceding the day of the Meeting, or any adjournment thereof, or with the Chairman of the Meeting on the day of the Meeting or any adjournment thereof, and upon either of such deposits the proxy is revoked. A proxy may also be revoked in any other manner permitted by law. The Company's registered office is located at Highvern Cayman Limited, Elgin Court, Elgin Avenue, George Town, Grand Cayman, KY1-1106, Cayman Islands.

------

**MANNER OF VOTING AND EXERCISE OF DISCRETION BY PROXIES**

The persons named in the enclosed form of proxy will vote or withhold from voting the common shares in respect of which they are appointed in accordance with the direction of the shareholders appointing them. **In the absence of such direction, such common shares will be voted FOR each of the matters identified in the Notice and described in this Circular.** 

The enclosed form of proxy confers discretionary authority upon the persons named therein with respect to amendments or variations to matters identified in the Notice, and with respect to other matters which may properly come before the Meeting. At the time of the printing of this Circular, management of the Company knows of no such amendments, variations or other matters to come before the Meeting other than the matters referred to in the Notice.

**VOTING BY NON-REGISTERED SHAREHOLDERS**

**Only shareholders whose names appear on the records of the Company as the registered holders of shares or their duly appointed proxyholders are permitted to vote at the Meeting.** Most shareholders of the Company are "non-registered" shareholders because the shares they own are not registered in their names but instead are registered in the name of a nominee such as a brokerage firm through which they purchased the shares; bank, trust company, trustee or administrator of self-administered RRSPs, RRIFs, RESPs and similar plans; or clearing agency such as The Canadian Depository for Securities Limited. If you purchased your shares through a broker, you are likely an unregistered shareholder.

In accordance with Canadian securities legislation, the Meeting materials are being sent to both registered and non-registered shareholders. In the case of non-registered shareholders, Meeting materials have either (a) been sent by the Company (or its agent) directly to non-registered shareholders (such non-registered shareholders are referred to under applicable securities legislation as "non-objecting beneficial owners"), or (b) been sent by the Company (or its agent) to intermediaries holding on behalf of non-registered shareholders for distribution to such non-registered shareholders. If you are a non-registered shareholder and the Company (or its agent) has sent the Meeting materials directly to you (which materials should include the Company's voting instruction form (the "**Company's VIF**")), your name and address and information about your holdings of securities have been obtained in accordance with applicable securities regulatory requirements from the intermediary holding on your behalf. By choosing to send these materials to you directly, the Company (and not the intermediary holding on your behalf) has assumed responsibility for (i) delivering these materials to you, and (ii) executing your proper voting instructions. Please return your voting instructions as specified in the next paragraph.

If you received the Meeting materials directly from the Company (or its agent) and you wish to vote by proxy at the Meeting, please complete the Company's VIF and return it to TSX Trust Company (the Company's transfer agent) by regular mail in the return envelope provided or by fax at (416) 595-9593. If you received the Meeting materials directly from the Company (or its agent) and you wish to vote at the Meeting in person, you should appoint yourself as proxyholder by writing your name in the blank space provided on the Company's VIF (and striking out the names of the persons designated in such form) and return the Company's VIF to TSX Trust Company by regular mail in the return envelope provided or by fax at (416) 595-9593 (do not complete the voting section of the form as your vote will be taken at the Meeting).

------

Intermediaries receiving Meeting materials from the Company are required to forward the materials to non-registered shareholders to seek their voting instructions in advance of the Meeting. The intermediaries often have their own form of proxy and mailing procedures and provide their own return instructions. If you received the Meeting materials from an intermediary and you wish to vote by proxy at the Meeting, you should carefully follow the instructions from the intermediary in order that your shares are voted at the Meeting. Your shares can only be voted in accordance with your instructions. If you wish to vote at the Meeting in person, you should appoint yourself as proxyholder by writing your name in the blank space provided on the proxy form provided by the intermediary (and striking out the names of the persons designated in such form) and return the form to the intermediary in the envelope provided (do not complete the voting section of the form as your vote will be taken at the Meeting).

The Company is not relying on the notice-and-access provisions of securities laws for delivery to either registered or non-registered shareholders. The Company has elected to pay for the delivery of the Meeting materials to objecting non-registered shareholders by intermediaries.

**VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF**

The authorized share capital of the Company consists of US$400,000 divided into 500,000,000 common shares with a par value of US$0.0008 per share. As of the date of this Circular, an aggregate of 38,906,742 common shares of the Company were issued and outstanding. Each common share entitles the holder thereof to one vote at all meetings of shareholders of the Company.

All shareholders of record at the close of business on May 27, 2025 will be entitled either to attend and vote at the Meeting in person the shares held by them or, provided a completed and executed proxy shall have been delivered to the Company as described above, to attend and vote thereat by proxy the shares held by them.

As of the date of this Circular, the only person or company who, to the knowledge of the directors and executive officers of the Company, beneficially owns, or controls or directs, directly or indirectly, 10% or more of the issued and outstanding common shares of the Company is as follows:

---

| | | |
|:---|:---|:---|
| <u>**Name**</u> | &nbsp;&nbsp; **Number of**<br><u>**Common Shares**</u> | &nbsp;&nbsp; **Total of**<br><u>**Common Shares**</u> |
| Arnold T. Kondrat <sup>(1)</sup> | &nbsp;&nbsp;20033188 | &nbsp;&nbsp;51.49% |

---

_________________________

(1) Mr. Kondrat is Chief Executive Officer, President and a director of the Company.

**CURRENCY**

As the Company's financial statements are prepared in United States dollars, all dollar amounts referred to in this Circular are expressed in United States dollars unless otherwise indicated. References in this Circular to "$" or "US$" are to United States dollars and references in this Circular to "Cdn$" are to Canadian dollars.

------

**ELECTION OF DIRECTORS**

The number of directors on the board of directors of the Company must consist of not more than fifteen (15) directors and not less than three (3) directors to be elected annually. The number of directors to be elected at the Meeting is three (3). The term of office of each of the present directors expires at the Meeting. The persons named below will be presented for election at the Meeting as management's nominees. Shareholders can vote for all of the proposed nominees, vote for some of the proposed nominees and withhold for others, or withhold for all of the proposed nominees. **Unless otherwise instructed, the persons named in the enclosed form of proxy intend to vote FOR the election of each of these nominees.** Management of the Company does not contemplate that any of the nominees will be unable to serve as a director, but if that should occur for any reason prior to the Meeting, the persons named in the enclosed form of proxy reserve the right to vote for another nominee in their discretion. Each director elected will hold office until the close of the first annual meeting of shareholders of the Company following his election unless his office is earlier vacated in accordance with the articles of association of the Company.

The following table and the notes thereto set out the name and municipality of residence of each person proposed to be nominated for election as a director, his current position and office with the Company, his present principal occupation(s) or employment, the date on which he was first elected or appointed a director of the Company, and the approximate number of common shares of the Company beneficially owned, or controlled or directed, directly or indirectly, as at the date of this Circular:

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp; <br>**Name, Current <br>Position(s) with the <br>Company and** <br> <u>**Municipality of Residence**</u> | <br><u>**Present Principal Occupation(s)**</u> | <br>**Director**<br><u>**Since**</u> | &nbsp;&nbsp;**Shares <br>Beneficially <br>Owned, <br>Controlled**<br><u>**or Directed**</u> <sup>(</sup><sup>1</sup><sup>)</sup> |
| &nbsp;&nbsp;Arnold T. Kondrat <sup>(2</sup><sup>)</sup><br>Chief Executive Officer, <br>President and a director <br>Toronto, Ontario, Canada | &nbsp;&nbsp;Chief Executive Officer and President of the Company; Executive Chairman of the Board of Directors of Loncor Gold Inc. (a gold exploration company); President of Sterling Portfolio Securities Inc. (a private venture capital firm). | &nbsp;&nbsp;July 31, 2007 | &nbsp;&nbsp;20033188 |
| &nbsp;&nbsp;Richard J. Lachcik <sup>(2</sup><sup>)</sup><br>Director<br>Wasaga Beach, Ontario, Canada | &nbsp;&nbsp;Prior to his retirement in 2017, Mr. Lachcik practiced corporate and securities law in Toronto, Canada for over 30 years. | &nbsp;&nbsp; <br>February 13, 2014 | &nbsp;&nbsp; <br>600000 |
| &nbsp;&nbsp;William R. Wilson <sup>(2)</sup><br>Director<br>Arvada, Colorado, U.S.A. | &nbsp;&nbsp;Self-employed mineral industry consultant (provides consulting services in the areas of corporate management, engineering and marketing). | &nbsp;&nbsp; <br>February 13, 2014 | &nbsp;&nbsp; <br>70000 |

---

_________________________

(1) The information as to shares beneficially owned, or controlled or directed, directly or indirectly, not being within the knowledge of the Company, has been furnished by the respective proposed directors individually.

(2) Member of the audit committee of the board of directors of the Company (the "**Audit Committee**").

------

<u>*Cease Trade Orders*</u>

None of the proposed directors of the Company as set forth in the above table is, as at the date of this Circular, or has been, within 10 years before the date of this Circular, a director, chief executive officer or chief financial officer of any company (including the Company) that:

(a) was subject to a cease trade order, an order similar to a cease trade order or an order that denied the relevant company access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days that was issued while such proposed director was acting in the capacity as director, chief executive officer or chief financial officer; or

(b) was subject to a cease trade order, an order similar to a cease trade order or an order that denied the relevant company access to any exemption under securities legislation, that was in effect for a period of more than 30 consecutive days, that was issued after such proposed director ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while such proposed director was acting in the capacity as director, chief executive officer or chief financial officer.

<u>*Corporate Bankruptcies*</u>

No proposed director of the Company as set forth in the above table (or any personal holding company of such proposed director), is, as of the date of this Circular, or has been within 10 years before the date of this Circular, a director or executive officer of any company (including the Company) that, while such proposed director was acting in that capacity, or within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets.

<u>*Personal Bankruptcies*</u>

No proposed director of the Company as set forth in the above table (or any personal holding company of such proposed director), has, within the 10 years before the date of this Circular, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or become subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold the assets of such proposed director.

<u>*Penalties or Sanctions*</u>

No proposed director of the Company, as set forth in the above table (or any personal holding company of such proposed director), has been subject to:

(a) any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities regulatory authority; or

(b) any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable securityholder in deciding whether to vote for a proposed director.

------

**APPOINTMENT OF AUDITORS**

Kreston GTA LLP, Licensed Public Accountants, are the current auditors of the Company and were first appointed auditors of the Company on January 16, 2020. Shareholders of the Company will be asked at the Meeting to reappoint Kreston GTA LLP as the Company's auditors, to hold office until the close of the next annual meeting of shareholders of the Company at such remuneration as may be approved by the directors of the Company. The resolution shareholders will be asked to approve with respect to such reappointment must be passed by a majority of the votes cast by shareholders at the Meeting in respect of this resolution. **Unless otherwise specified, the persons named in the enclosed form of proxy will vote FOR the said reappointment of Kreston GTA LLP.** 

**REAPPROVAL OF STOCK OPTION PLAN**

The Company has a stock option plan (the "**Option Plan**"), which was established in December 2011. A complete copy of the Option Plan is attached to this Circular as Schedule "B". Shareholders of the Company approved a certain amendment to the Option Plan at the annual and special meeting of shareholders of the Company held on August 31, 2018. The following is a summary of certain terms of the Option Plan:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Stock options may be granted from time to time by the board of directors of the Corporation (the "**Board**") to such directors, officers, employees and consultants of the Company or a subsidiary of the Company, and in such numbers, as are determined by the Board at the time of the granting of the stock options.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The total number of common shares of the Company ("**Common Shares**") issuable upon the exercise of all outstanding stock options granted under the Option Plan shall not at any time exceed 10% of the total number of outstanding Common Shares, from time to time. The Company currently does not have outstanding under the Option Plan any stock options. The total number of stock options that may be granted under the Option Plan, based on the number of Common Shares currently outstanding, is stock options to purchase a total of 3,890,674 Common Shares (such number of shares is equal to 10% of the number of Common Shares which are currently outstanding).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The exercise price of each stock option shall be determined in the discretion of the Board at the time of the granting of the stock option, provided that the exercise price shall not be lower than the "Market Price". "**Market Price**" means the last closing price of the Common Shares on the TSX Venture Exchange prior to the date the stock option is granted.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) At no time shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the number of Common Shares reserved for issuance pursuant to stock options granted to insiders of the Company exceed 10% of the outstanding Common Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the number of stock options granted to insiders of the Company, within a 12-month period, exceed 10% of the outstanding Common Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) the number of Common Shares reserved for issuance pursuant to stock options or pursuant to any other stock purchase or option plans of the Company granted to any one optionee exceed 5% of the outstanding Common Shares;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) the number of Common Shares issued pursuant to stock options to any one optionee, within a one-year period, exceed 5% of the outstanding Common Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) the number of stock options granted to any one consultant in a 12-month period exceed 2% of the outstanding Common Shares; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) the aggregate number of stock options granted to persons employed in investor relations activities exceed 2% of the outstanding Common Shares in any 12-month period without the express consent of the TSX Venture Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) In the event a "take-over bid" (as such term is defined under Ontario securities laws) is made in respect of the Common Shares, all stock options shall become exercisable (subject to any necessary regulatory approval) so as to permit the holders of such stock options to tender the Common Shares received upon exercising such stock options pursuant to the take-over bid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) All stock options shall be for a term determined in the discretion of the Board at the time of the granting of the stock options, provided that no stock option shall have a term exceeding five years and, unless the Board at any time makes a specific determination otherwise (but subject to the terms of the Option Plan), a stock option and all rights to purchase Common Shares pursuant thereto shall expire and terminate immediately upon the optionee who holds such stock option ceasing to be at least one of a director, officer or employee of or consultant to the Company or a subsidiary of the Company, as the case may be.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Unless otherwise determined by the Board at the time of the granting of the stock options, one-quarter of the stock options granted to an optionee vest on each of the 6 month, 12 month, 18 month and 24 month anniversaries of the grant date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Except in limited circumstances in the case of the death of an optionee, stock options shall not be assignable or transferable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Disinterested shareholder approval is required prior to any reduction in the exercise price of a stock option if the optionee holding such stock option is an insider of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) The Company may amend from time to time the terms and conditions of the Option Plan by resolution of the Board. Any amendments shall be subject to the prior consent of any applicable regulatory bodies, including the TSX Venture Exchange (to the extent such consent is required).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) The Board has full and final discretion to interpret the provisions of the Option Plan, and all decisions and interpretations made by the Board shall be binding and conclusive upon the Company and all optionees, subject to shareholder approval if required by the TSX Venture Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) The Option Plan does not provide for financial assistance by the Company to an optionee in connection with an option exercise.

The Common Shares are listed on the NEX Board of the TSX Venture Exchange. The rules of the TSX Venture Exchange require that the Option Plan be reapproved annually. Shareholders of the Company will therefore be asked at the Meeting to consider and, if thought advisable, to reapprove by means of an ordinary resolution the Option Plan and the granting of stock options from time to time pursuant thereto. The resolution shareholders will be asked to approve is as follows:

------

*BE IT RESOLVED THAT:*

&nbsp;&nbsp;&nbsp;&nbsp;*1. the Company's stock option plan (the "**Option Plan**"), a copy of which is attached as Schedule "B" to the management information circular of the Company dated May 27, 2025, and the granting of stock options from time to time pursuant thereto, be and are hereby reapproved; and* 

&nbsp;&nbsp;&nbsp;&nbsp;*2. any one director or officer of the Company be and is hereby authorized and directed to execute and deliver on behalf of the Company all such documents and instruments and to do all such other acts and things as in his or her opinion may be necessary or desirable in connection with the foregoing.* 

To be approved, the above resolution must be passed by a majority of the votes cast by shareholders at the Meeting in respect of this resolution. **Unless otherwise specified, the persons named in the enclosed form of proxy will vote FOR the resolution.** 

**SHARE CONSOLIDATION**

Shareholders of the Company, at the annual and special meeting of shareholders held on June 27, 2024, passed a special resolution authorizing the consolidation of the issued and outstanding Common Shares by changing each two (2) Common Shares into one (1) Common Share, and the adoption of an amendment to the memorandum of association of the Company to reflect the said share consolidation. The special resolution also provided that the latest the share consolidation could be implemented by was June 27, 2025.

The Board has to date not carried out the said potential share consolidation. As the shareholder authorization for this potential share consolidation expires on June 27, 2025, and as the Board may decide, in the best interests of the Company, to implement the potential share consolidation after June 27, 2025 in order to assist in attracting additional capital for the Company, shareholders will be asked at the Meeting to renew the shareholder authorization for the potential share consolidation for another year.

To reflect the consolidation of the Common Shares, the memorandum of association of the Company must be amended. Such an amendment must be authorized by a special resolution of shareholders. Shareholders of the Company will therefore be asked at the Meeting to consider and, if thought advisable, to authorize by means of a special resolution, the consolidation of the issued and outstanding Common Shares by changing each two (2) Common Shares into one (1) Common Share (the "**Share Consolidation**"), and the adoption of an amendment to the memorandum of association of the Company to reflect the Share Consolidation. No fractional Common Shares will be issued in connection with the Share Consolidation and, in the event that a shareholder would otherwise be entitled to receive a fractional share upon the Share Consolidation, the number of Common Shares to be received by such shareholder will be rounded up to the next highest whole number of Common Shares. The special resolution shareholders will be asked to approve is as follows:

------

*BE IT RESOLVED AS A SPECIAL RESOLUTION THAT:*

&nbsp;&nbsp;&nbsp;&nbsp;*1. conditional upon the approval of the board of directors of the Company in its sole discretion, with effect as of the date the board of directors of the Company may determine (but in no case later than June 27, 2026):* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(a) the issued and outstanding common shares of the Company be consolidated by changing each two (2) common shares of the Company into one (1) common share of the Company (the "**Share Consolidation**");*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(b) the adoption of an amendment to the memorandum of association of the Company to reflect the Share Consolidation be and is hereby authorized; and*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*(c) no fractional common shares of the Company shall be issued in connection with the Share Consolidation and, in the event that a shareholder would otherwise be entitled to receive a fractional share upon the Share Consolidation, the number of common shares of the Company to be received by such shareholder shall be rounded up to the next highest whole number of common shares;*

&nbsp;&nbsp;&nbsp;&nbsp;*2. any one director or officer of the Company be and is hereby authorized, for and on behalf of the Company, to execute and deliver, or cause to be delivered, an amendment to the memorandum of association of the Company, as required pursuant to the Companies Law (2018 Revision) of the Cayman Islands, if and when deemed advisable by the board of directors of the Company in its sole discretion (but in no case later than June 27, 2026), and to do all such other acts or things necessary or desirable to implement, carry out and give effect to the Share Consolidation.* 

To be approved, the above special resolution must be passed by not less than two-thirds of the votes cast by shareholders at the Meeting in respect of this special resolution. **Unless otherwise specified, the persons named in the enclosed form of proxy will vote FOR the special resolution.**

The Share Consolidation, if implemented, will not materially affect the percentage ownership in the Company of shareholders even though such ownership will be represented by a smaller number of Common Shares. The Share Consolidation will merely proportionally reduce the number of Common Shares held by shareholders.

The Share Consolidation, if implemented, may result in some shareholders owning "odd lots" of fewer than 500 Common Shares on a post-Share Consolidation basis. Odd lots may be more difficult to sell, or require greater transaction costs per share to sell, than Common Shares in "board lots" of even multiples of 500 shares.

**Notwithstanding that the above special resolution is passed at the Meeting, the directors of the Company may determine not to proceed with the Share Consolidation without further approval or authorization of, or notice to, the shareholders of the Company.** 

In the event that shareholders pass the above special resolution at the Meeting to consolidate the Common Shares and the Board determines to implement the Share Consolidation, the presently issued and outstanding 38,906,742 Common Shares will be consolidated into approximately 19,453,371 Common Shares, subject to the rounding of fractional shares pursuant to the Share Consolidation.

If the Board decides to proceed with the Share Consolidation (assuming that the above special resolution is passed at the Meeting), a letter of transmittal will be sent by mail to registered shareholders of the Company advising them that the Share Consolidation has been approved by the Board, and instructing them how to surrender their currently held share certificates ("**Old Share Certificates**") for replacement share certificates representing the number of Common Shares to which they are entitled as a result of the Share Consolidation. No delivery of a new share certificate to a shareholder will be made until the shareholder has surrendered his or her Old Share Certificate. Until surrendered, each Old Share Certificate will be deemed for all purposes to represent the number of Common Shares to which the holder thereof is entitled as a result of the Share Consolidation. Beneficial holders of Common Shares ("**Beneficial Shareholders**") holding their Common Shares through an intermediary (if you purchased your shares through a broker, your shares are likely held through an intermediary) should note that such intermediary may have different procedures for processing the Share Consolidation than those that will be put in place by the Company for registered shareholders. Beneficial Shareholders that hold Common Shares with an intermediary are encouraged to contact such intermediary with respect to any questions in this regard.

------

**AUDIT COMMITTEE MATTERS**

National Instrument 52-110 (*Audit Committees*) (the "**Instrument**") provides that the disclosure required by Form 52-110F2 must be included in this Circular. The following addresses the applicable items identified in Form 52-110F2.

<u>*The Audit Committee's Charter*</u>

The text of the Audit Committee's charter is attached to this Circular as Schedule "A".

<u>*Composition of the Audit Committee*</u>

The members of the Audit Committee are as follows: Arnold T. Kondrat, Richard J. Lachcik and William R. Wilson. Each such member is "financially literate" within the meaning of the Instrument. Each of Mr. Wilson and Mr. Lachcik is "independent" within the meaning of the Instrument, and Mr. Kondrat (who is President and Chief Executive Officer of the Company) is not "independent" within the meaning of the Instrument.

<u>*Relevant Education and Experience of Audit Committee Members*</u>

Arnold T. Kondrat - Mr. Kondrat is the Company's principal founder and has over 30 years of management experience in the resource exploration industry. During this time, he has been an officer and director of a number of publicly-traded resource exploration companies, in both Canada and the United States. He has been a director of the Company since July 2007, was Executive Vice President of the Company from July 2007 to February 2014 and has been the President and Chief Executive Officer of the Company since February 2014.

Richard J. Lachcik - Prior to his retirement in 2017, Mr. Lachcik practiced corporate and securities law in Toronto, Canada for over 30 years. His practice included extensive experience in representing public companies, as well as acting for a number of investment dealers. Mr. Lachcik has been a member of the board of directors of many junior mineral exploration companies such as the Company, and been a member of the audit committee of several of these companies.

William R. Wilson - Mr. Wilson holds a Masters of Business Administration (M.B.A.) from the University of Southern California. He has been a director and senior officer of a number of public companies in both Canada and the United States, and has been a member of the audit committee of several of these companies.

------

<u>*Pre-Approval Policies and Procedures*</u>

The Audit Committee has not adopted specific policies or procedures for the engagement of non-audit services.

<u>*External Auditors Service Fees*</u>

The following summarizes the total fees billed by the external auditors of the Company (Kreston GTA LLP) for each of the years ended December 31, 2024 and December 31, 2023. All dollar amounts are exclusive of applicable taxes.

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;<u>**2024**</u> | &nbsp;&nbsp;<u>**2023**</u> |
| Audit Fees | &nbsp;&nbsp;US$12,550 | &nbsp;&nbsp;US$14,967 |
| Audit-Related Fees | &nbsp;&nbsp;- | &nbsp;&nbsp;- |
| Tax Fees | &nbsp;&nbsp;US$4,000 | &nbsp;&nbsp;US$3,799 |
| All Other Fees | &nbsp;&nbsp;- | &nbsp;&nbsp;- |

---

<u>*Exemption*</u>

The Company is relying upon the exemption set out in section 6.1 of the Instrument.

**EXECUTIVE COMPENSATION**

**Compensation Discussion and Analysis**

The purpose of this Compensation Discussion and Analysis is to provide certain information about the compensation of the Company's executives. The identified named officers of the Company (the "**NEOs**") who appear in the compensation tables of this section of the Circular are: Arnold T. Kondrat, President and Chief Executive Officer of the Company, and Donat K. Madilo, Chief Financial Officer of the Company.

As the Company's business has been the exploration of mineral properties, the Company often has had to operate with limited financial resources and control costs to ensure that funds are available to complete scheduled programs and otherwise fund its operations. As a result, the Board has attempted to keep the cash compensation paid to the Company's executives modest, while providing long-term incentives through the granting of stock options. This is consistent with the Company's objective of preserving cash and also reflects the Company's belief that incentive stock options offer an effective mechanism for incentivizing management and aligning the interests of the Company's executive officers with those of the Company's shareholders.

***Compensation Governance***

Among its other duties, the Board is responsible for (i) overseeing the Company's executive compensation, management succession and development and equity compensation plans, and (ii) ensuring that the Company's executive compensation programs are appropriate and reflect the long-term interest of the Company and its shareholders. Given the size of the Company and the number of directors on the Board, the Board has not delegated any of the above responsibilities to a committee of the Board and performs such functions itself. In performing its duties, the Board has the authority to engage such advisors, including executive compensation consultants, as it considers necessary.

------

No policies or practices have been adopted by the Board to determine the compensation for the Company's directors or executive officers. A compensation consultant or advisor has not, at any time since the Company's most recently completed financial year, been retained to assist the Board in determining compensation for any of the Company's directors or executive officers.

***Compensation Process***

The Company does not have a formal process for determining executive compensation, but rather, relies on Board discussion as needed as determined by the Board. There are no formal criteria or analysis in respect of executive compensation. The Board believes that the existing compensation arrangements with the Company's executives are appropriate in light of, among other things, the Company's business and current stage of development.

Stock options are generally granted by the Board to executives upon their commencement of service. Additional grants will also be made periodically to executives (a) to recognize exemplary performance or a special contribution, or (b) to provide additional long-term incentives. The Board determines the particulars with respect to stock option grants.

***Compensation Strategy***<u> </u>

The Company strives to ensure that the compensation provided to the Company's executives is determined with regard to the Company's business strategy and objectives, such that the financial interests of executives are matched with the financial interests of the shareholders. The Company also strives to ensure that the Company's executives are compensated fairly and commensurately with their contributions to furthering the Company's strategic direction and objectives. The Company's compensation program is intended to attract, motivate and retain top quality individuals. Having regard to these objectives of attracting, motivating and retaining, the program takes into account, as applicable, the location of the Company's operations in foreign jurisdictions.

<u>Compensation Risk Management</u>

The Board evaluates the risks, if any, associated with the Company's compensation policies and practices. Implicit in the Board's mandate is that the Company's policies and practices respecting compensation, including those applicable to the Company's NEOs, be designed in a manner which is in the best interests of the Company and its shareholders. Risk evaluation is one of the considerations for this review.

A portion of the Company's executive compensation consists of stock options granted under the Company's stock option plan. Such compensation is both "long term" and "at risk" and, accordingly, is directly linked to the achievement of long-term value creation. Since the benefits of such compensation, if any, are generally not realized by an executive until a significant period of time has passed, the possibility of executives taking inappropriate or excessive risks with regard to their compensation that are financially beneficial to them at the expense of the Company and its shareholders is extremely limited. In addition, all major transactions require approval by the Board.

The other two elements of compensation, salary and bonus, are capped to ensure preservation of capital and to provide upper payout boundaries, thereby reducing risks associated with unexpectedly high levels of pay. In addition, the Board believes it is unlikely that executives would take inappropriate or excessive risks at the expense of the Company and its shareholders that would be beneficial to them with regard to their short-term compensation when their longer-term compensation might be put at risk from their actions.

------

Due to the size of the Company, and the current level of the Company's activity, the Board is able to closely monitor and consider any risks which may be associated with the Company's compensation policies and practices. Risks, if any, may be identified and mitigated through regular Board meetings during which financial and other information of the Company are reviewed, and which includes executive compensation. No risks have been identified arising from the Company's compensation policies and practices that are reasonably likely to have a material adverse effect on the Company.

The Company has a policy prohibiting directors and officers of the Company from purchasing financial instruments, including, for greater certainty, prepaid variable forward contracts, equity swaps, collars, or units of exchange funds, that are designed to hedge or offset a decrease in market value of equity securities granted as compensation or held, directly or indirectly, by the director or officer.

<u>Compensation Mix</u>

Standard compensation arrangements for the Company's executives are composed of the following elements, which are linked to the Company's compensation and corporate objectives as follows:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Compensation**<br>**Element** | &nbsp;&nbsp;**Link to**<br>**Compensation Objectives** | &nbsp;&nbsp;<br>**Link to Corporate Objectives** |
| &nbsp;&nbsp;Base salary | &nbsp;&nbsp;• Attract and retain<br>• Reward | &nbsp;&nbsp;• Competitive pay ensures access to skilled personnel necessary to achieve corporate objectives. |
| &nbsp;&nbsp;Bonuses | &nbsp;&nbsp;• Motivate and reward | &nbsp;&nbsp;• Bonuses focus executives on the achievement of corporate objectives and reward exceptional performance.<br>• Competitive pay ensures access to skilled employees necessary to achieve corporate objectives. |
| &nbsp;&nbsp;Stock options | &nbsp;&nbsp;• Attract and retain<br>• Motivate and reward<br>• Align interests with shareholders | &nbsp;&nbsp;• Stock option grants motivate and reward executives to increase shareholder value by the achievement of long-term corporate strategies and objectives.<br>• Encourages long-term tenure and performance. |
| &nbsp;&nbsp;Benefits | &nbsp;&nbsp;• Attract and retain | &nbsp;&nbsp;• Competitive benefits ensure access to skilled employees necessary to achieve corporate objectives. |

---

*Base Salary* 

Base salaries represent the minimum compensation for services rendered during the fiscal year. Base salaries depend on the executive's experience, responsibilities, skills and performance, general industry trends and practices, the Company's circumstances, including its existing financial resources, and the potential long-term compensation provided by stock options as discussed below. In addition to the above factors, decisions regarding any salary increases are impacted by the executive's current salary.

------

*Bonuses* 

While the Company has not yet established a formal annual bonus program, executives are generally eligible to receive an annual cash bonus subject to the Company's financial position. Executives may also receive from time to time during the year cash bonuses to recognize exemplary performance or a special contribution. No bonuses were paid to the NEOs in respect of fiscal 2024 (or 2023) in order to conserve cash, having regard to the Company's current financial situation.

*Stock Options*

The grant of options to purchase Common Shares is an integral component of the compensation package which the Company can provide to its executives. The Board believes that stock option grants serve to motivate achievement of the Company's long-term strategic objectives and the result will benefit all shareholders. Decisions in respect of stock option grants are based in part upon the level of responsibility and contribution of the individuals toward the Company's goals and objectives. As well, the overall number of stock options outstanding relative to the number of outstanding Common Shares is also considered in determining whether to make any new grants of stock options and the size of such grants.

No stock options of the Company were granted to the NEOs in 2024 or 2023.

*Benefits* 

Senior officers are eligible to participate in the same benefits as offered to all full-time employees. This includes participation in a traditional employee benefit plan consisting of health and dental care and life insurance. The Company does not view these benefits as a significant element of its compensation structure, as they constitute only a small percentage of total compensation, but does believe that benefits be used in conjunction with base salary to attract and retain individuals in a competitive environment. The Company does not currently have standard senior officer perks, but may provide such perks as is considered appropriate.

**Executive Compensation: Tables and Narrative** 

***Summary Compensation Table***

The following table provides a summary of the compensation earned by the NEOs for services rendered in all capacities during the indicated financial years.

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Name and<br>Principal<br>Position(s)** | &nbsp;&nbsp;**Year** | &nbsp;&nbsp;**Salary**<br>**(US$)** | &nbsp;&nbsp;**Share-<br>based<br>awards**<br>**(US$)** | &nbsp;&nbsp;**Total<br>Compensation<br>(US$)** |
| &nbsp;&nbsp;Arnold T. Kondrat<br>Chief Executive Officer | &nbsp;&nbsp;2024<br>2023<br>2022 | &nbsp;&nbsp;$87673<br>$88665<br>$92269 | &nbsp;&nbsp;N/A<br>N/A<br>N/A &nbsp;&nbsp;Nil<br>Nil<br>Nil &nbsp;&nbsp;Nil<br>Nil<br>$2,064 <sup>(2)</sup> | &nbsp;&nbsp;$87673<br>$88665<br>$94333 |
| &nbsp;&nbsp;Donat K. Madilo<br>Chief Financial Officer | &nbsp;&nbsp;2024<br>2023<br>2022 | &nbsp;&nbsp;$50000<br>$50000<br>$50000 | &nbsp;&nbsp;N/A<br>N/A<br>N/A &nbsp;&nbsp;Nil<br>Nil<br>Nil &nbsp;&nbsp;Nil<br>Nil<br>$2,042 <sup>(2)</sup> | &nbsp;&nbsp;$50000<br>$50000<br>$52042 |

---

------

_________________________

(1) The Company did not grant any stock options in 2024, 2023 or 2022.

(2) This amount represents medical insurance premiums paid by the Company.

The Company does not have any long-term incentive program other than its stock option plan and does not have any defined or actuarial plans.

***Incentive Plan Awards***

As at December 31, 2024, the Company did not have outstanding any option or share-based awards.

During the year ended December 31, 2024, the Company did not have any option-based awards, share-based awards or non-equity incentive plan compensation which vested or was earned.

***Pension Plan Benefits and Deferred Compensation Plans***

The Company does not have a pension plan or a deferred compensation plan.

***Termination and Change of Control Benefits***

There is no contract, agreement, plan or arrangement that provides for payments to a NEO at, following or in connection with any termination (whether voluntary, involuntary or constructive), resignation, retirement, a change in control of the Company or a change in a NEO's responsibilities.

**Director Compensation**

The directors of the Company were not paid any fees by the Company during the financial year ended December 31, 2024 for their services in their capacity as directors.

The Company's directors are eligible to receive stock option grants under the Company's stock option plan, as determined by the Board. The exercise price of such stock options is determined by the Board, but shall in no event be less than the last closing price of the Company's Common Shares on the TSX Venture Exchange prior to the date the stock options are granted.

All directors of the Company are entitled to receive reimbursement for reasonable out-of-pocket expenses related to their attendance at meetings or other expenses incurred for Company purposes.

<u>Director Summary Compensation Table</u>

The following table sets out certain information with respect to the compensation of each of the Company's directors in the year ended December 31, 2024, other than Mr. Kondrat. See "Summary Compensation Table" above for details regarding the compensation of Mr. Kondrat during 2024.

------

16 <br>

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Name** | &nbsp;&nbsp;**Share-based<br>awards**<br>**(US$)** | &nbsp;&nbsp;**Non-equity<br>incentive plan<br>compensation**<br>**(US$)** |
| &nbsp;&nbsp;Richard J. Lachcik &nbsp;&nbsp;Nil | &nbsp;&nbsp;N/A &nbsp;&nbsp;Nil | &nbsp;&nbsp;N/A &nbsp;&nbsp;Nil |
| &nbsp;&nbsp;William R. Wilson &nbsp;&nbsp;Nil | &nbsp;&nbsp;N/A &nbsp;&nbsp;Nil | &nbsp;&nbsp;N/A &nbsp;&nbsp;Nil |

---

_________________________

(1) The Company did not grant any stock options in 2024.

<u>Incentive Plan Awards</u>

As at December 31, 2024, the Company did not have outstanding any option or share-based awards,

During the year ended December 31, 2024, the Company did not have any option-based awards, share-based awards or non-equity incentive plan compensation which vested or was earned.

**SECURITIES ISSUABLE UNDER EQUITY COMPENSATION PLANS**

The following table sets forth, as at December 31, 2024, the number of Common Shares to be issued upon the exercise of any outstanding options, warrants and rights issued pursuant to equity compensation plans, the weighted average exercise price of such outstanding options, warrants and rights and the number of Common Shares remaining available for future issuance under equity compensation plans of the Company.

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Plan Category** | &nbsp;&nbsp;**Number of Common Shares<br>to be issued upon exercise<br>of any options, warrants<br>and rights outstanding as at<br>Dec. 31, 2024 <sup>(1)</sup>** | &nbsp;&nbsp;**Weighted-average<br>exercise price of<br>options, warrants<br>and rights<br>outstanding as at<br>Dec. 31, 2024 <sup>(1)</sup>** | &nbsp;&nbsp;**Number of Common Shares<br>remaining available for future<br>issuance under equity<br>compensation plans as at <br>Dec. 31, 2024 (excluding shares<br>reflected in the first column)** |
| &nbsp;&nbsp;Equity compensation plans approved by shareholders <sup>(1)</sup> | &nbsp;&nbsp;Nil | &nbsp;&nbsp;N/A | &nbsp;&nbsp;3890674 |
| &nbsp;&nbsp;Equity compensation plans not approved by shareholders | &nbsp;&nbsp;N/A | &nbsp;&nbsp;N/A | &nbsp;&nbsp; N/A |
| &nbsp;&nbsp;Totals | &nbsp;&nbsp;Nil | &nbsp;&nbsp;N/A | &nbsp;&nbsp;3890674 |

---

_________________________

(1) The only equity compensation plan of the Company approved by shareholders is the Company's stock option plan. As at December 31, 2024, the Company did not have outstanding under the Company's stock option plan any stock options.

------

**INDEBTEDNESS OF DIRECTORS AND EXECUTIVE OFFICERS**

As of the date of this Circular, no current or former executive officer, director or employee of the Company or a subsidiary of the Company is indebted to the Company or a subsidiary of the Company.

As of the date of this Circular, no current or former executive officer, director or employee of the Company or a subsidiary of the Company has indebtedness to another entity which is the subject of a guarantee, support agreement, letter of credit or other similar arrangement or understanding provided by the Company or a subsidiary of the Company.

**INTEREST OF INFORMED PERSONS IN MATERIAL TRANSACTIONS**

No director or officer of the Company, no person or company that beneficially owns, or controls or directs, directly or indirectly, more than 10% of the outstanding Common Shares (a "**10% Shareholder**"), no director or officer of a 10% Shareholder or of a subsidiary of the Company and no associate or affiliate of any of the foregoing persons or companies, has or has had any material interest, direct or indirect, in any transaction since the beginning of the Company's financial year ended December 31, 2024 or in any proposed transaction which, in either case, has materially affected or will materially affect the Company or any of its subsidiaries.

**FINANCIAL STATEMENTS** 

The audited consolidated financial statements of the Company as at and for the financial year ended December 31, 2024 (the "**2024 Financial Statements**"), together with the auditors' report thereon, will be placed before the Meeting.

**CORPORATE GOVERNANCE MATTERS**

The Board is committed to sound corporate governance practices, which are both in the interest of its shareholders and contribute to effective and efficient decision making.

National Instrument 58-101 (which is entitled "Disclosure of Corporate Governance Practices") provides that the corporate governance disclosure required by Form 58-101F2 must be included in this Circular. The following addresses the items identified in Form 58-101F2.

***Board of Directors***

A director is considered "independent" if he has no direct or indirect material relationship with the Company. A "material relationship" is a relationship which could, in the view of the Board, be reasonably expected to interfere with the exercise of a director's independent judgment. The Board consists of three persons: two of the directors have been determined to be independent and the third has been determined to not be independent. William R. Wilson and Richard J. Lachcik are independent and Arnold T. Kondrat (who is Chief Executive Officer and President and the largest shareholder of the Company) is not independent of the Company.

The Board facilitates its exercise of independent judgment in carrying out its responsibilities by having a majority of independent directors on the Board and the Audit Committee. The Board also believes that the fiduciary duties placed on individual directors by the *Companies Law (2018 Revision)* of the Cayman Islands (the Company's governing corporate legislation) and by the common law and the restrictions placed by such legislation on an individual directors' participation in decisions of the Board in which the director has an interest ensure that the Board operates independently of management and in the best interests of the Company.

------

***Directorships***

The following directors of the Company are presently directors of other issuers that are reporting issuers (or the equivalent):

---

| | |
|:---|:---|
| <u>Name of Director</u> | <u>Names of Other Issuers</u> |
| Arnold T. Kondrat | Loncor Gold Inc. |
| Richard J. Lachcik | Loncor Gold Inc. |
| William R. Wilson | Loncor Gold Inc. |

---

***Orientation and Continuing Education***

Due to the size of the Board, no formal program currently exists for the orientation of new directors. Each new director brings a different skill set and professional background, and with this information, the Board is able to determine what orientation to the nature and operations of the Company's business will be necessary and relevant to each new director.

No formal continuing education program currently exists for the Company's directors. Each of the Company's directors has the responsibility for ensuring that he maintains the skill and knowledge necessary to meet his obligations as a director. The Company's legal counsel advises the Board on any changes in laws or regulations relevant to the duties and responsibilities of directors.

***Ethical Business Conduct***

The Board expects management to operate the business of the Company in a manner that enhances shareholder value and is consistent with the highest level of integrity.

The Board has adopted a code of business conduct and ethics for directors, officers and employees (the "**Code**"). A copy of the Code may be obtained from the Chief Financial Officer of the Company at (416) 361-2510 and is also be available on SEDAR+ at www.sedarplus.ca. Each director, officer and employee of the Company is provided with a copy of the Code and is required to confirm annually that he or she has complied with the Code. Any observed breaches of the Code must be reported to the Company's Chief Executive Officer.

The Board has also adopted a "whistleblower" policy which provides employees, consultants, officers and directors with the ability to report, on a confidential and anonymous basis, violations within the Company's organization, including (but not limited to), questionable accounting practices, disclosure of fraudulent or misleading financial information, instances of corporate fraud, or harassment. The Board believes that providing a forum for such individuals to raise concerns about ethical conduct and treating all complaints with the appropriate level of seriousness fosters a culture of ethical business conduct.

------

Under the Company's articles of association, a director of the Company may only be (a) a party to, or otherwise interested in, any transaction or arrangement with the Company or in which the Company is or may otherwise be interested, or (b) be interested in another corporation in which the Company is interested, if the director discloses the nature and extent of his interest to the other directors of the Company and such other directors resolve to approve the director's interest. Such a director may only vote on any resolution concerning a matter in which the director has an interest if he has disclosed such interest in accordance with the Company's articles of association. In addition, in certain cases, an independent committee of the Board may be formed to deliberate on such matters in the absence of the interested party.

***Nomination of Directors***

The Board determines new nominees to the Board, although a formal process has not been adopted. The nominees are generally the result of recruitment efforts by the Board members, including both formal and informal discussions among Board members and officers.

***Compensation***

See the disclosure in this Circular under "Executive Compensation".

***Other Board Committees***

The Board does not have any standing committees other than the Audit Committee.

***Assessments***

The Board monitors but does not formally assess the performance of the Board, the Audit Committee and individual Board members. To date, the Board has satisfied itself, through informal discussions, that the Board, the Audit Committee and individual Board members are performing effectively.

**ADDITIONAL INFORMATION**

Financial information relating to the Company is provided in the 2024 Financial Statements and the Company's management's discussion and analysis relating to such financial statements (the "**2024 MD&A**"). Copies of this Circular, the 2024 Financial Statements, the 2024 MD&A, the interim consolidated financial statements of the Company subsequent to the 2024 Financial Statements and the Company's management's discussion and analysis relating to such interim financial statements, as well as additional information relating to the Company, are available on SEDAR+ at www.sedarplus.ca. Copies of such documents may also be obtained without charge by writing to the Chief Financial Officer of the Company at 4120 Yonge Street, Suite 304, Toronto, Ontario, M2P 2B8, Canada.

------

**DIRECTORS' APPROVAL**

The contents of this Circular and the sending thereof to the shareholders of the Company have been approved by the Board. Unless otherwise indicated, information contained in this Circular is given as of May 27, 2025.

**DATED** the 27th day of May, 2025.

**BY ORDER OF THE BOARD** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(signed) *"Geoffrey G. Farr"*

Geoffrey G. Farr

Corporate Secretary

------

<u>**SCHEDULE "A"**</u>

**Gentor Resources Inc.**

Terms of Reference

Audit Committee of the Board of Directors

Gentor Resources Inc.

September 30, 2011

<u>**Mandate**</u>

**A.** <u>**Role and Objectives**</u>

The audit committee (the "**Committee**") is a committee of the board of directors (the "**Board**") of Gentor Resources Inc. ("**Gentor**") established for the purpose of overseeing the accounting and financial reporting process of Gentor and external audits of the consolidated financial statements of Gentor. In connection therewith, the Committee assists the Board in fulfilling its oversight responsibilities in relation to Gentor's internal accounting standards and practices, financial information, accounting systems and procedures, financial reporting and statements and the nature and scope of the annual external audit. The Committee also recommends for Board approval Gentor's audited annual consolidated financial statements and other mandatory financial disclosure.

Gentor's external auditor is accountable to the Board and the Committee as representatives of shareholders of Gentor. The Committee shall be directly responsible for overseeing the relationship of the external auditor. The Committee shall have such access to the external auditor as it considers necessary or desirable in order to perform its duties and responsibilities. The external auditor shall report directly to the Committee.

The objectives of the Committee are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. to be satisfied with the credibility and integrity of financial reports;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. to support the Board in meeting its oversight responsibilities in respect of the preparation and disclosure of financial reporting, including the consolidated financial statements of Gentor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. to facilitate communication between the Board and the external auditor and to receive all reports of the external auditor directly from the external auditor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. to be satisfied with the external auditor's independence and objectivity; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. to strengthen the role of independent directors by facilitating in-depth discussions between members of the Committee, management and Gentor's external auditor.

------

**B.** <u>**Composition**</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The Committee shall comprise at least 3 directors. The composition of the Committee shall satisfy the independence, financial literacy and experience requirements of applicable corporate and securities laws, any applicable stock exchange requirements or guidelines and any other applicable regulatory rules. Determinations as to whether a particular director satisfies the requirements for membership on the Committee shall be made by the full Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Members of the Committee shall be appointed by the Board. Each member shall serve until his successor is appointed, unless he shall resign or be removed by the Board or he shall otherwise cease to be a director of Gentor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. The Chair of the Committee may be designated by the Board or, if it does not do so, the members of the Committee may elect a Chair by vote of a majority of the full Committee membership.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The Committee shall have access to such officers and employees of Gentor and to such information respecting Gentor as it considers to be necessary or advisable in order to perform its duties and responsibilities.

**C.** <u>**Meetings**</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. At all meetings of the Committee, every question shall be decided by a majority of the votes cast. In case of an equality of votes, the matter will be referred to the Board for decision.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. A quorum for meetings of the Committee shall be a majority of its members.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Meetings of the Committee shall be scheduled at such times during each year as the Committee deems appropriate. Minutes of all meetings of the Committee shall be taken. The Chief Financial Officer shall attend meetings of the Committee, unless otherwise excused from all or part of any such meeting by the Committee Chair.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The Committee shall report the results of meetings and reviews undertaken and any associated recommendations to the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The Committee shall meet periodically with Gentor's external auditor (in connection with the preparation of the annual consolidated financial statements and otherwise as the Committee may determine), part or all of each such meeting to be in the absence of management.

<u>**Responsibilities**</u>

As discussed above, the Committee is established to assist the Board in fulfilling its oversight responsibilities with respect to the accounting and financial reporting processes of Gentor and external audits of Gentor's consolidated financial statements. In that regard, the Committee shall:

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. satisfy itself on behalf of the Board with respect to Gentor's internal control systems including identifying, monitoring and mitigating business risks as well as compliance with legal, ethical and regulatory requirements. The Committee shall also review with management, the external auditor and, if necessary, legal counsel, any litigation, claim or other contingency (including tax assessments) that could have a material effect on the financial position or operating results of Gentor (on a consolidated basis), and the manner in which these matters may be, or have been, disclosed in the financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. review with management and the external auditor the annual consolidated financial statements of Gentor, the reports of the external auditor thereon and related financial reporting, including Management's Discussion and Analysis and any earnings press releases, (collectively, "**Annual Financial Disclosure**") prior to their submission to the Board for approval. This process should include, but not be limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) reviewing changes in accounting principles, or in their application, which may have a material impact on the current or future year's financial statements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) reviewing significant accruals, reserves or other estimates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) reviewing accounting treatment of unusual or non-recurring transactions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) reviewing adequacy of reclamation fund;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) reviewing disclosure requirements for commitments and contingencies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) reviewing financial statements and all items raised by the external auditor, whether or not included in the financial statements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) reviewing unresolved differences between Gentor and the external auditor.

Following such review, the Committee shall recommend to the Board for approval all Annual Financial Disclosure;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. review with management all interim consolidated financial statements of Gentor and related financial reporting, including Management's Discussion and Analysis and any earnings press releases, (collectively "**Quarterly Financial Disclosure**") and, if thought fit, approve all Quarterly Financial Disclosure;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. be satisfied that adequate procedures are in place for the review of Gentor's public disclosure of financial information extracted or derived from Gentor's financial statements, other than Annual Financial Disclosure or Quarterly Financial Disclosure, and shall periodically assess the adequacy of those procedures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. review with management and recommend to the Board for approval, any financial statements of Gentor which have not previously been approved by the Board and which are to be included in a prospectus of Gentor;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. review with management and recommend to the Board for approval, Gentor's annual information form prescribed by any applicable Canadian securities laws (if Gentor is required to file an annual information form);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. with respect to the external auditor:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) receive all reports of the external auditor directly from the external auditor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) discuss with the external auditor:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) critical accounting policies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) alternative treatments of financial information within GAAP discussed with management (including the ramifications thereof and the treatment preferred by the external auditor); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) other material, written communication between management and the external auditor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) consider and make a recommendation to the Board as to the appointment or re-appointment of the external auditor, being satisfied that such auditor is a participant in good standing pursuant to applicable securities laws;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) review the terms of engagement of the external auditor, including the appropriateness and reasonableness of the auditor's fees and make a recommendation to the Board as to the compensation of the external auditor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) when there is to be a replacement of the external auditor, review with management the reasons for such replacement and the information to be included in any required notice to securities regulators and recommend to the Board for approval the replacement of the external auditor along with the content of any such notice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) oversee the work of the external auditor in performing its audit or review services and oversee the resolution of any disagreements between management and the external auditor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) review and discuss with the external auditor all significant relationships that the external auditor and its affiliates have with Gentor and its affiliates in order to determine the external auditor's independence, including, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) requesting, receiving and reviewing, on a periodic basis, written or oral information from the external auditor delineating all relationships that may reasonably be thought to bear on the independence of the external auditor with respect to Gentor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) discussing with the external auditor any disclosed relationships or services that the external auditor believes may affect the objectivity and independence of the external auditor; and

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) recommending that the Board take appropriate action in response to the external auditor's information to satisfy itself of the external auditor's independence;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) as may be required by applicable securities laws, rules and guidelines, either:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) pre-approve all non-audit services to be provided by the external auditor to Gentor (and its subsidiaries, if any), or, in the case of *de minimus* non-audit services, approve such non-audit services prior to the completion of the audit; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) adopt specific policies and procedures for the engagement of the external auditor for the purposes of the provision of non-audit services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) review and approve the hiring policies of Gentor regarding partners, employees and former partners and employees of the present and former external auditor of Gentor;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. (a) establish procedures for:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the receipt, retention and treatment of complaints received by Gentor regarding accounting, internal accounting controls or auditing matters; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the confidential, anonymous submission by employees of Gentor of concerns regarding questionable accounting or auditing matters; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) review with the external auditor its assessment of the internal controls of Gentor, its written reports containing recommendations for improvement, and Gentor's response and follow-up to any identified weaknesses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. with respect to risk management, be satisfied that Gentor has implemented appropriate systems of internal control over financial reporting (and review senior management's assessment thereof) to ensure compliance with any applicable legal and regulatory requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. review annually with management and the external auditor and report to the Board on insurable risks and insurance coverage; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. engage independent counsel and other advisors as it determines necessary to carry out its duties and set and pay the compensation for any such advisors.

------

<u>**SCHEDULE "B"**</u>

**GENTOR RESOURCES INC.**

**Stock Option Plan**

The board of directors of Gentor Resources Inc. (the "Corporation") wishes to establish a stock option plan (the "Plan") governing the issuance of stock options (the "Stock Options") to directors, officers and employees of the Corporation or subsidiaries of the Corporation and persons or corporations who provide services to the Corporation or its subsidiaries on an on-going basis, or have provided or are expected to provide a service or services of considerable value to the Corporation or its subsidiaries. Capitalized terms, not otherwise defined herein, have the meanings ascribed thereto in the TSX Venture Exchange Corporate Finance Manual.

The terms and conditions of the Plan for issuance of Stock Options are as follows:

1. <u>**Purposes**</u>

The principal purposes of the Plan are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) to retain and attract qualified directors, officers, employees and service providers which the Corporation and its subsidiaries require;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) to promote a proprietary interest in the Corporation and its subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) to provide an incentive element in compensation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) to promote the profitability of the Corporation and its subsidiaries.

2. <u>**Reservation of Shares**</u>

The total number of common shares in the capital of the Corporation ("Common Shares") issuable upon the exercise of all outstanding Stock Options granted under this Plan shall not at any time exceed 10% of the total number of outstanding Common Shares, from time to time.

3. <u>**Eligibility**</u>

Stock Options shall be granted only to persons, firms or corporations ("Eligible Optionees") who are Directors, Employees, Consultants or Management Company Employees of the Corporation or a subsidiary of the Corporation. Where the Eligible Optionee is an Employee, Consultant or Management Company Employee, the board of directors of the Corporation (the "Board") shall confirm that the Eligible Optionee is a bona fide Employee, Consultant or Management Company Employee, as the case may be, of the Corporation or a subsidiary of the Corporation prior to any grant of Stock Options.

Stock Options may also be granted to a corporation which is wholly-owned by an Eligible Optionee if the corporation agrees not to effect or permit any transfer of ownership or option of shares of the corporation, nor to issue further shares of any class in the corporation to any other individual or entity as long as any Stock Options granted to the corporation remain outstanding, without the prior written consent of the TSX Venture Exchange. Unless the context otherwise requires, the term Eligible Optionee as used herein, shall include any such corporation.

------

4. <u>**Granting of Stock Options**</u>

The Board may from time to time grant Stock Options to Eligible Optionees. At the time a Stock Option is granted, the Board shall determine the number of Common Shares of the Corporation available for purchase under the Stock Option, the date when the Stock Option is to become effective and, subject to the other provisions of this Plan, all other terms and conditions of the Stock Option. An Eligible Optionee may hold more than one Stock Option at any time, however, at no time shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the number of Common Shares reserved for issuance pursuant to stock options granted to Insiders under this Plan and under any other stock purchase or option plans of the Corporation, exceed 10% of the outstanding Common Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the number of stock options granted to Insiders under this Plan and under any other stock purchase or option plans of the Corporation, within a 12 month period, exceed 10% of the outstanding Common Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the number of Common Shares reserved for issuance pursuant to stock options granted to any one person, firm or corporation under this Plan and under any other stock purchase or option plans of the Corporation, exceed 5% of the outstanding Common Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) the number of Common Shares issued pursuant to stock options under this Plan and under any other stock purchase or option plans of the Corporation to any one person, firm or corporation, within a one-year period, exceed 5% of the outstanding Common Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) the number of Stock Options granted to any one Consultant in a 12 month period exceed 2% of the outstanding Common Shares; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) the aggregate number of Stock Options granted to persons employed in Investor Relations Activities exceed 2% of the outstanding Common Shares in any 12 month period without the express consent of the TSX Venture Exchange.

Any Stock Options granted to a corporation referred to in Section 3 hereof shall be included in the calculation of the Stock Options held by an Eligible Optionee.

5. <u>**Exercise Price**</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The exercise price (the "Exercise Price") of each Stock Option shall be determined in the discretion of the Board at the time of the granting of the Stock Option, provided that the exercise price shall not be lower than the "Market Price". "Market Price" shall mean the last closing price of the Common Shares on the TSX Venture Exchange prior to the date the Stock Option is granted; provided that in the event the Common Shares are not listed on the TSX Venture Exchange but are listed on another stock exchange or stock exchanges, the foregoing reference to the TSX Venture Exchange shall be deemed to be a reference to such other stock exchange, or if more than one, to such one as shall be designated by the Board, and to the extent that the Common Shares are not listed on any exchange, the Market Price shall be such price as is determined by the Board in good faith.

6. <u>**Term and Exercise Periods**</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All Stock Options shall be for a term determined in the discretion of the Board at the time of the granting of the Stock Options, provided that no Stock Option shall have a term exceeding five years and, unless the Board at any time makes a specific determination otherwise, a Stock Option and all rights to purchase Common Shares pursuant thereto shall expire and terminate immediately upon the Eligible Optionee who holds such Stock Option ceasing to be at least one of a Director, Employee, Management Company Employee or Consultant of the Corporation or a subsidiary of the Corporation.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Unless otherwise determined by the Board at the time of the granting of the Stock Options pursuant to clause 6(c)(iii) below, 1/4 of the Stock Options granted pursuant hereto will vest on each of the 6 month, 12 month, 18 month and 24 month anniversaries of the date of the grant of the Stock Options (the "Grant Date"). For greater clarity, unless otherwise determined pursuant to the terms hereof, all Stock Options granted to an Eligible Optionee will be available to exercise and purchase Common Shares on the 24 month anniversary of the Grant Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) By way of example, without limiting the generality of the foregoing or the discretion of the Board, the Board may, at the time of the granting of the Stock Option, determine:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) that a Stock Option is exercisable only while the Eligible Optionee remains at least one of a Director, Employee, Management Company Employee or Consultant and for a limited period of time ("Additional Period") after the Eligible Optionee ceases to be at least one of a Director, Employee, Management Company Employee or Consultant (which Additional Period may not exceed 90 days or, in the case of an Eligible Optionee engaged in Investor Relations Activities, 30 days);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) that a Stock Option can be exercisable for an Additional Period or for its remaining term (which Additional Period or remaining term may not exceed one year) after the death, disability or incapacity of an Eligible Optionee;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) that a Stock Option has a different vesting schedule than that specified in subsection 6(b) above; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) that a Stock Option may provide for early exercise and/or termination or other adjustment in the event of a death of a person and in other circumstances, such as if the Corporation shall resolve to sell all or substantially all of its assets, to liquidate or dissolve, or to merge, amalgamate, consolidate or be absorbed with or into any other corporation.

7. <u>**Non-Assignability**</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than a limited right of assignment, subject to the terms upon which the Stock Option is granted, in the event of the death of an Eligible Optionee to allow the exercise of Stock Options by the Eligible Optionee's legal representative, Stock Options shall not be assignable or transferable by the Eligible Optionees.

8. <u>**Payment of Exercise Price**</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All shares issued pursuant to the exercise of a Stock Option shall be paid for in full at the time of exercise of the Stock Option and prior to the issue of the shares. All Common Shares issued in accordance with the foregoing shall be issued as fully paid and non-assessable Common Shares.

------

9. <u>**Non-Exercise**</u>

If any Stock Option granted pursuant to the Plan is not exercised for any reason whatsoever, upon the expiry of the Stock Options pursuant to the terms of its grant or the terms hereof, the shares reserved and authorized for issuance pursuant to such Stock Option shall revert to the Plan and shall be available for other Stock Options. Notwithstanding the foregoing, at no time shall there be outstanding Stock Options exceeding, in the aggregate, the number of Common Shares reserved for issuance pursuant to Stock Options under this Plan.

10. <u>**Adjustment in Certain Circumstances**</u>

In the event:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) of any change in the Common Shares through subdivision, consolidation, reclassification, amalgamation, merger or otherwise; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) of any stock dividend to holders of Common Shares (other than such stock dividends issued at the option of shareholders of the Corporation in lieu of substantially equivalent cash dividends); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) that any rights are granted to holders of Common Shares to purchase Common Shares at prices substantially below fair market value; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) that as a result of any recapitalization, merger, consolidation or otherwise the Common Shares are converted into or exchangeable for any other shares;

then in any such case the Board may make such adjustment in the Plan and in the Stock Options granted under the Plan as the Board may in its sole discretion deem appropriate to prevent substantial dilution or enlargement of the rights granted to, or available for, holders of Stock Options, and such adjustments may be included in the Stock Options.

11. <u>**Expenses**</u>

All expenses in connection with the Plan shall be borne by the Corporation.

12. <u>**Compliance with Laws**</u>

The Corporation shall not be obliged to issue any shares upon exercise of Stock Options if the issue would violate any law or regulation or any rule of any governmental authority or stock exchange. The Corporation shall not be required to issue, register or qualify for resale any shares issuable upon exercise of Stock Options pursuant to the provisions of a prospectus or similar document, provided that the Corporation shall notify the TSX Venture Exchange or any other stock exchange on which the shares of the Corporation are listed and any other appropriate regulatory bodies of the existence of the Plan and the issuance and exercise of Stock Options.

In addition to any resale restrictions that may be applicable under applicable securities laws, all Stock Options and any shares issued on the exercise of Stock Options shall be legended with a four month hold period from the date the Stock Options are granted.

------

13. <u>**Disinterested Shareholder Approval**</u>

Disinterested shareholder approval shall be obtained by the Corporation prior to any reduction in the Exercise Price if the Optionee is an Insider of the Corporation at the time of a proposed reduction of the Exercise Price.

14. <u>**Form of Stock Option Agreement**</u>

All Stock Options shall be issued by the Corporation in a form which meets the general requirements and conditions set forth in this Plan and the requirements of the TSX Venture Exchange or such other exchange on which the shares of the Corporation are listed from time to time.

15. <u>**General Offer for Common Shares**</u>

If a bona fide offer (the "Offer") for the Common Shares is made to shareholders generally, which Offer, if accepted in whole or in part, would result in the offeror exercising control over the Corporation within the meaning of subsection 1(3) of the *Securities Act* (Ontario), then the Corporation shall, immediately upon receipt of notice of the Offer, notify each Eligible Optionee then holding Stock Options of the Offer, with full particulars thereof, whereupon, notwithstanding clause 6(b) hereof but subject to any necessary regulatory approval, such Stock Options may be exercised in whole or in part by the Eligible Optionee so as to permit the Eligible Optionee to tender the Common Shares received upon such exercise (the "Optioned Shares") pursuant to the Offer. If:

&nbsp;&nbsp;&nbsp;&nbsp;(a) the Offer is not completed within the time specified therein; or

&nbsp;&nbsp;&nbsp;&nbsp;(b) the Eligible Optionee does not tender the Optioned Shares pursuant to the Offer; or

&nbsp;&nbsp;&nbsp;&nbsp;(c) all of the Optioned Shares tendered by the Eligible Optionee pursuant to the Offer are not taken up and paid for by the offeror in respect thereof,

then the Optioned Shares or, in the case of clause (c) above, the Optioned Shares that are not taken up and paid for, shall be returned by the Eligible Optionee to the Corporation and reinstated as authorized but unissued Common Shares and the terms of the Stock Options as set forth in clause 6(b) hereof shall again apply to the Stock Options. If any Optioned Shares are returned to the Corporation under this Section 15, the Corporation shall refund the Exercise Price to the Eligible Optionee for such Optioned Shares. In no event shall the Eligible Optionee be entitled to sell the Optioned Shares otherwise than pursuant to the Offer.

16. <u>**Amendments and Termination**</u>

The Corporation shall retain the right to (a) amend from time to time the terms of the Plan or to terminate the Plan by resolution of the Board, and (b) amend from time to time the terms of outstanding Stock Options by resolution of the Board. Any such amendments or termination shall be subject to the consent of any applicable regulatory body, including any stock exchange on which the Corporation's shares are listed (to the extent such consent is required). Any amendment to the terms of outstanding Stock Options shall be subject to the consent of the Eligible Optionee holding such Stock Options. Any amendment to the terms of the Plan shall take effect only with respect to Stock Options granted thereafter, provided that such amendment may apply to any Stock Options previously granted with the consent of the Eligible Optionees holding such Stock Options.

------

17. <u>**Delegation of Administration of the Plan**</u>

Subject to the legislation governing the Corporation, the Board may delegate to one or more directors of the Corporation, on such terms as it considers appropriate, all or any part of the powers, duties and functions relating to the granting of Stock Options and the administration of the Plan.

18. <u>**Applicable Law**</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Plan shall be governed by and construed in accordance with the laws in force in the Province of Ontario, Canada.

19. <u>**Stock Exchange**</u>

To the extent applicable, the issuance of any shares of the Corporation pursuant to Stock Options issued pursuant to this Plan is subject to approval of the Plan by the TSX Venture Exchange or other stock exchange upon which the Common Shares are listed, and the Plan shall be subject to the ongoing requirements of such exchange.

20. <u>**Administration**</u>

This Plan shall be administered by the Board. The Board shall have full and final discretion to interpret the provisions of this Plan and to prescribe, amend, rescind and waive rules and regulations to govern the administration and operation of this Plan. All decisions and interpretations made by the Board shall be binding and conclusive upon the Corporation and on all persons eligible to participate in this Plan, subject to shareholder approval if required by any stock exchange on which the Corporation's shares are listed.

------

## Exhibit 99.3

------

**GENTOR RESOURCES INC.**

4120 Yonge Street, Suite 304

Toronto, Ontario, M2P 2B8, Canada

**FORM OF PROXY SOLICITED BY THE MANAGEMENT OF**

**GENTOR RESOURCES INC. FOR USE AT THE ANNUAL AND SPECIAL <br>MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 27, 2025**

The undersigned shareholder(s) of GENTOR RESOURCES INC. (the "**Company**") hereby appoint(s) in respect of all of his or her shares of the Company, Donat K. Madilo, Chief Financial Officer of the Company, or failing him, Geoffrey G. Farr, Corporate Secretary of the Company, or in lieu of the foregoing __________________________________ as nominee of the undersigned, with power of substitution, to attend, act and vote for the undersigned at the annual and special meeting (the "**Meeting**") of shareholders of the Company to be held on the 27th day of June, 2025, and any adjournment or adjournments thereof, and direct(s) the nominee to vote the shares of the undersigned in the manner indicated below:

&nbsp;&nbsp;&nbsp;&nbsp;**1.** On the election of the following nominees as directors of the Company, as described in the Company's management information circular dated May 27, 2025 (the "**Circular**").

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp; <u>VOTE FOR</u> | &nbsp;&nbsp; <u>WITHHOLD VOTE</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Arnold T. Kondrat | &nbsp;&nbsp; ☐ | &nbsp;&nbsp; ☐ |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Richard J. Lachcik | &nbsp;&nbsp; ☐ | &nbsp;&nbsp; ☐ |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; William R. Wilson | &nbsp;&nbsp; ☐ | &nbsp;&nbsp; ☐ |

---

&nbsp;&nbsp;&nbsp;&nbsp;**2.** VOTE FOR ☐ WITHHOLD VOTE ☐ on reappointing Kreston GTA LLP, Licensed Public Accountants, as the auditors of the Company, to hold office until the close of the next annual meeting of shareholders of the Company at such remuneration as may be approved by the directors of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**3.** VOTE FOR ☐ AGAINST ☐ the ordinary resolution reapproving the Company's Stock Option Plan, as required pursuant to the rules of the NEX Board of the TSX Venture Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;**4.** VOTE FOR ☐ AGAINST ☐ the special resolution authorizing the consolidation of the issued and outstanding common shares of the Corporation by changing each two (2) common shares of the Company into one (1) common share of the Company (the "**Share Consolidation**"), and the adoption of an amendment to the memorandum of association of the Company to reflect the Share Consolidation, as described in the Circular.

If any amendments or variations to matters identified in the Notice of the Meeting are proposed at the Meeting or if any other matters properly come before the Meeting, this proxy confers discretionary authority to vote on such amendments or variations or such other matters according to the best judgment of the person voting the proxy at the Meeting.

**DATED** the day of , 2025.

---

| |
|:---|
| Signature of Shareholder(s) |
| Print Name |
| *(see notes on the back of this page)* |

---

------

**NOTES:**<br> (1) The form of proxy must be dated and signed by the appointor or his or her attorney authorized in writing or, if the appointor is a body corporate, the form of proxy must be executed by an officer or attorney thereof duly authorized. If the proxy is not dated, it will be deemed to bear the date on which it was mailed. The proxy ceases to be valid one year from its date.<br> (2) Where a choice with respect to any matter to be acted upon at the Meeting has been specified in the form of proxy, the shares represented by the form of proxy will be voted or withheld from voting in accordance with the specifications so made. The shares represented by the form of proxy will be voted or withheld from voting in accordance with the instructions of the shareholder on any ballot that may be called for.<br> **(3) A SHAREHOLDER HAS THE RIGHT TO APPOINT A PERSON (WHO NEED NOT BE A SHAREHOLDER) TO ATTEND AND ACT FOR HIM OR HER AND ON HIS OR HER BEHALF AT THE MEETING OTHER THAN THE PERSONS DESIGNATED IN THE FORM OF PROXY. SUCH RIGHT MAY BE EXERCISED BY STRIKING OUT THE NAMES OF THE PERSONS DESIGNATED IN THE FORM OF PROXY AND BY INSERTING IN THE BLANK SPACE PROVIDED FOR THAT PURPOSE THE NAME OF THE DESIRED PERSON OR BY COMPLETING ANOTHER FORM OF PROXY AND, IN EITHER CASE, DELIVERING THE COMPLETED AND EXECUTED PROXY TO THE COMPANY C/O TSX TRUST COMPANY, 301 - 100 ADELAIDE STREET WEST, TORONTO, ONTARIO, M5H 4H1, CANADA, AT ANY TIME PRIOR TO 4:00 P.M. (TORONTO TIME) ON THE 25TH DAY OF JUNE, 2025, OR TO THE CHAIRMAN OF THE MEETING ON THE DAY OF THE MEETING OR ANY ADJOURNMENT THEREOF PRIOR TO THE TIME FOR VOTING.** <br> **(4) IN THE ABSENCE OF INSTRUCTIONS TO THE CONTRARY, THE PERSONS NAMED IN THE PROXY WILL VOTE FOR EACH OF THE MATTERS IDENTIFIED IN THE PROXY.**<br> (5) If your address as shown is incorrect, please give your correct address when returning the proxy.<br>

------

## Exhibit 99.4

------

![](exhibit99-4xu001.jpg)

------

![](exhibit99-4xu002.jpg)

------

## Exhibit 99.5

------

**GENTOR RESOURCES INC.** 

**FINANCIAL STATEMENT AND MD&A REQUEST FORM**

In accordance with securities legislation, shareholders of Gentor Resources Inc. (the "**Corporation**") may elect annually to receive a copy of the Corporation's quarterly interim consolidated financial statements and related management's discussion and analysis ("**MD&A**"), the Corporation's annual consolidated financial statements and related MD&A, or both.

If you wish to receive copies of these documents, please complete this form and return it to the following address (shareholders must renew their requests to receive these documents each year):

TSX Trust Company

301 - 100 Adelaide Street West

Toronto, Ontario, M5H 4H1

Canada

 ☐ Please send me ONLY the quarterly interim consolidated financial statements and related MD&A.

 ☐ Please send me ONLY the annual consolidated financial statements and related MD&A.

 ☐ Please send me BOTH the quarterly interim consolidated financial statements and the annual consolidated financial statements, and the respective MD&A for such statements. 

Copies of the Corporation's annual and quarterly consolidated financial statements and related MD&A are also available on the SEDAR+ website at www.sedarplus.ca.

---

| | |
|:---|:---|
| &nbsp;&nbsp; <br>DATED:<u> </u><u> </u><u> </u>, 2025. | &nbsp;&nbsp; <br>__________________________________________<br>Signature<br>*I confirm that I am a shareholder of the Corporation.* |
|  | &nbsp;&nbsp; <br>__________________________________________<br>Name of Shareholder - Please Print |
|  | &nbsp;&nbsp; <br>__________________________________________<br>Address |
|  | &nbsp;&nbsp; <br>__________________________________________ |
|  | &nbsp;&nbsp; <br>__________________________________________ |
|  | &nbsp;&nbsp; <br>__________________________________________<br>Name and title of person signing if different from the name above. |

---

The Corporation will use the information collected solely for the purpose of mailing the financial statements and MD&A to you and will treat your signature on this form as your consent to the above.

------